← Evidence map

ArticleScientific reports2025

The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis.

Shiwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39753653